ProVerum Medical develops minimally invasive devices utilizing a proprietary technology to treat benign prostatic hyperplasia, a condition that causes urinary obstruction in men. Their approach aims to reduce patient recovery time and minimize complications associated with traditional surgical methods.
Funding
$43.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
GHLVFounders
Product
Problem
Benign prostatic hyperplasia (BPH) causes urinary obstruction in men, leading to discomfort and reduced quality of life. Traditional surgical treatments for BPH can be invasive, resulting in extended recovery times and potential complications.
Solution
ProVerum Medical is developing minimally invasive devices that utilize a proprietary technology to treat BPH. Their approach aims to alleviate urinary obstruction while minimizing the trauma associated with traditional surgical methods. By reducing invasiveness, ProVerum seeks to shorten patient recovery time and decrease the risk of complications. The company's focus is on improving the patient experience and outcomes in BPH treatment through innovative device design.
Target Audience
The primary target audience is men experiencing urinary obstruction due to benign prostatic hyperplasia.
Features
- Minimally invasive device for BPH treatment
- Proprietary technology to reduce trauma during the procedure
- Designed to alleviate urinary obstruction
- Aims to shorten patient recovery time compared to traditional surgery
- Focus on minimizing complications associated with BPH treatment